Vectorite Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Market Capitalization	602	613	635	935	621	621	Upgrade
Market Cap Growth	10.00%	-3.45%	-32.08%	50.46%	-	26.25%	Upgrade
Enterprise Value	432	437	442	728	396	375	Upgrade
Last Close Price	13.75	14.00	14.50	21.35	14.01	14.01	Upgrade
PE Ratio	6.28	6.37	-	-	-	74.32	Upgrade
PS Ratio	9.80	9.98	10.99	16.73	14.47	21.59	Upgrade
PB Ratio	1.24	1.26	1.63	2.17	1.41	1.33	Upgrade
P/TBV Ratio	1.24	1.26	1.66	2.29	1.49	1.40	Upgrade
P/FCF Ratio	-	-	-	-	44.96	-	Upgrade
P/OCF Ratio	-	-	-	719.97	42.25	-	Upgrade
EV/Sales Ratio	7.03	7.12	7.65	13.04	9.23	13.03	Upgrade
EV/FCF Ratio	-44.14	-	-	-	28.67	-	Upgrade
Net Debt / Equity Ratio	-0.35	-0.35	-0.47	-0.47	-0.48	-0.51	Upgrade
Net Debt / EBITDA Ratio	12.38	12.38	10.74	29.21	9.85	9.23	Upgrade
Net Debt / FCF Ratio	17.42	17.42	12.88	58.92	-15.46	3.54	Upgrade
Asset Turnover	0.13	0.13	0.13	0.12	0.09	0.07	Upgrade
Inventory Turnover	2.67	2.67	3.29	5.31	6.99	4.97	Upgrade
Quick Ratio	10.73	10.73	12.91	16.45	14.10	14.53	Upgrade
Current Ratio	11.85	11.85	14.06	17.53	14.93	15.07	Upgrade
Return on Equity (ROE)	21.98%	21.98%	-9.77%	-1.52%	-5.83%	2.05%	Upgrade
Return on Assets (ROA)	-2.97%	-2.97%	-3.75%	-2.20%	-3.98%	-6.15%	Upgrade
Return on Capital Employed (ROCE)	-4.40%	-4.40%	-6.50%	-3.70%	-6.80%	-8.90%	Upgrade
Earnings Yield	15.98%	15.69%	-6.31%	-0.71%	-4.25%	1.35%	Upgrade
FCF Yield	-1.63%	-1.60%	-2.26%	-0.37%	2.22%	-10.88%	Upgrade
Buyback Yield / Dilution	-0.87%	-0.47%	0.14%	-	-1.84%	-47.01%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.